In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Roche chief executive Thomas Schinecker said today that one in five of the pharma division’s pipeline of new molecular entities (NMEs) has been culled in the last few months as part of a shift ...

A federal judge has awarded $171,595 – the equivalent of 8,580 manicures at $20 per session – to a former employee of an Armonk nail salon.

The Canadian comedian's latest target has been Meghan Markle as she has publicly laid into her in the wake of her much-derided Netflix series, With Love, Meghan. And Meghan is not the first ...

March 12, 2025 • While Trump's executive order takes aim at Perkins Coie, the judge said it "casts a chilling harm of blizzard proportion across the entire legal profession." ...

Serving as a gateway between international legal practitioners in the U.S. and those practicing around the globe. The International Law Section is dedicated to bringing together lawyers from around ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics , the Wall Street Journal reported on Wednesday, citing ...